{"product_id":"chemotox-report-breat-cancer","title":"ChemoTox Report - Breast Cancer","description":"\u003cdiv style=\"max-width: 900px; font-family: inherit; color: #111; line-height: 1.45;\"\u003e\n\n  \u003ch2 style=\"font-size: 26px; font-weight: 700; margin: 0 0 22px;\"\u003e\n    ChemoTox Report™ – Breast Cancer\n  \u003c\/h2\u003e\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 0 0 38px; line-height: 1.3;\"\u003e\n    Genetic Screening to Help Identify Chemotherapy Toxicity Risk\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 24px; font-weight: 700; margin: 0 0 16px;\"\u003e\n    $495 + HST\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    Chemotherapy can be highly effective in treating breast cancer, but each person's body\n    processes medications differently. Genetic differences can affect the enzymes and\n    pathways involved in breaking down certain chemotherapy medications, which may\n    influence medication exposure and the risk of serious side effects.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    ChemoTox Report™ – Breast Cancer is a pharmacogenomic screening designed to\n    identify genetic factors that may affect how your body processes selected breast cancer\n    medications. The results provide your oncology team with additional information that\n    may help support safer, more personalized treatment decisions.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 28px;\"\u003e\n    Testing can be completed before chemotherapy begins or during treatment. Understanding\n    your genetic profile may help your healthcare provider identify potential medication\n    toxicity risks and determine whether additional precautions, monitoring, dose\n    considerations, or treatment adjustments may be appropriate.\n  \u003c\/p\u003e\n\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 28px 0 14px;\"\u003e\n    Why Your Genetics Matter\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    Your body relies on specific enzymes to metabolize and clear medications. Genetic\n    variations can reduce the activity of some of these enzymes, causing certain medications\n    to remain in the body longer or reach higher concentrations than expected.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    One important example involves fluoropyrimidine chemotherapy medications such as\n    capecitabine and 5-Fluorouracil (5-FU). The DPYD gene helps determine the activity\n    of the DPD enzyme, which is responsible for breaking down most fluorouracil in the body.\n    Certain DPYD genetic variants can significantly reduce DPD activity and increase the\n    risk of serious or potentially life-threatening toxicity.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 28px;\"\u003e\n    Identifying clinically relevant genetic variations before treatment gives your oncology\n    team additional information that can be considered alongside your diagnosis, treatment\n    plan, medical history, laboratory results, and other clinical factors.\n  \u003c\/p\u003e\n\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 28px 0 14px;\"\u003e\n    What's Included\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 10px;\"\u003e\n    Your ChemoTox Report™ – Breast Cancer includes:\n  \u003c\/p\u003e\n\n  \u003cul style=\"font-size: 18px; margin: 0 0 30px 25px; padding: 0;\"\u003e\n\n    \u003cli style=\"margin-bottom: 8px;\"\u003e\n      Multi-gene pharmacogenomic analysis focused on chemotherapy metabolism and\n      toxicity risk\n    \u003c\/li\u003e\n\n    \u003cli style=\"margin-bottom: 8px;\"\u003e\n      Analysis of clinically relevant genetic variants associated with selected breast\n      cancer medications\n    \u003c\/li\u003e\n\n    \u003cli style=\"margin-bottom: 8px;\"\u003e\n      Evaluation of genetic factors that may influence medication metabolism,\n      exposure, and toxicity\n    \u003c\/li\u003e\n\n    \u003cli style=\"margin-bottom: 8px;\"\u003e\n      Professional clinical report designed for review by your oncologist or\n      healthcare provider\n    \u003c\/li\u003e\n\n    \u003cli style=\"margin-bottom: 8px;\"\u003e\n      Medical review by a clinical MD\/PhD\n    \u003c\/li\u003e\n\n    \u003cli style=\"margin-bottom: 8px;\"\u003e\n      Personalized genetic information that may help your healthcare team make\n      more informed treatment decisions\n    \u003c\/li\u003e\n\n  \u003c\/ul\u003e\n\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 30px 0 14px;\"\u003e\n    Supporting Safer, More Personalized Cancer Treatment\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    Your oncologist selects chemotherapy based on the characteristics of your cancer and\n    your individual treatment needs. ChemoTox Report™ provides another layer of\n    information by examining genetic factors that may influence how your body processes\n    certain chemotherapy medications.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 28px;\"\u003e\n    The goal is to give you and your oncology team additional information before and\n    during treatment so that potential genetic risk factors can be considered when making\n    treatment decisions.\n  \u003c\/p\u003e\n\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 30px 0 14px;\"\u003e\n    When Should You Get Tested?\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    Ideally, pharmacogenomic screening can be completed before chemotherapy begins,\n    giving your healthcare provider an opportunity to review your results as part of your\n    treatment planning.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 28px;\"\u003e\n    If you have already started treatment, genetic information may still provide useful\n    information about how your body processes certain medications and can be reviewed\n    by your healthcare provider during your treatment journey.\n  \u003c\/p\u003e\n\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 30px 0 14px;\"\u003e\n    At-Home DNA Collection\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 16px;\"\u003e\n    ChemoTox Report™ begins with a simple, non-invasive DNA sample that can be\n    collected at home. Your sample is then sent to the laboratory for genetic analysis.\n  \u003c\/p\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 28px;\"\u003e\n    Once the analysis is complete, your results are interpreted and presented in a\n    professional clinical report designed to be reviewed with your healthcare provider.\n  \u003c\/p\u003e\n\n\n  \u003ch3 style=\"font-size: 21px; font-weight: 700; margin: 30px 0 14px;\"\u003e\n    Laboratory \u0026amp; Medical Review\n  \u003c\/h3\u003e\n\n  \u003cp style=\"font-size: 18px; margin: 0 0 28px;\"\u003e\n    ChemoTox Report™ is medically reviewed by a clinical MD\/PhD. Genetic testing is\n    processed through PGX Lab Solutions, a College of American Pathologists (CAP)\n    accredited laboratory with ISO 9001 and ISO 27001 certifications.\n  \u003c\/p\u003e\n\n\n  \u003cp style=\"font-size: 18px; font-weight: 700; margin: 30px 0 0;\"\u003e\n    Please note: ChemoTox Report™ does not diagnose cancer, determine whether\n    chemotherapy is required, or replace the clinical judgment of your oncologist or\n    healthcare provider. Treatment and dosing decisions should always be made by your\n    healthcare team.\n  \u003c\/p\u003e\n\n\u003c\/div\u003e","brand":"Personalized Prescribing","offers":[{"title":"Default Title","offer_id":47510618243234,"sku":null,"price":495.0,"currency_code":"CAD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0462\/9705\/5394\/files\/chemotox-kit-box.png?v=1786385075","url":"https:\/\/store.personalizedprescribing.com\/products\/chemotox-report-breat-cancer","provider":"Personalized Prescribing","version":"1.0","type":"link"}